Enphase Energy Inc vs Select Medical Holdings Corporation — how do they compare? Enphase Energy Inc trades at $41.58 (market cap $5.81B), while Select Medical Holdings Corporation trades at $16.51 (market cap $2.05B). The key difference: Enphase Energy Inc is far larger — about 2.8× Select Medical Holdings Corporation's market cap, and Select Medical Holdings Corporation pays a 1.51% dividend while Enphase Energy Inc pays none. Which is the better fit depends on your goals.
| ENPH | SEM | |
|---|---|---|
Market Cap | $5.81B | $2.05B |
Sector | Technology | Health |
52-Week High | $72.33 | $16.66 |
52-Week Low | $26.12 | $11.77 |
Enterprise Value | $5.46B | $5.01B |
Dividend Yield | — | 1.51% |
Signals from Pluang's Aura AI — not financial advice
Enphase Energy (ENPH) trades at $44.985, up 4.47% with a neutral technical signal despite bullish moving averages. The company has beaten earnings expectations for three consecutive quarters, though revenue declined from $2.3B in 2023 to $1.47B in 2025. Analyst sentiment is mixed with 40% buy ratings but a consensus price target of $42.79 below current levels. Recent news highlights product expansions in Europe and Australia alongside ongoing legal scrutiny.
ENPH faces near-term headwinds with declining revenue and compressed margins, but maintains strong profitability metrics and consistent earnings beats. Investment appeal hinges on international growth execution and potential regulatory tailwinds, balanced against competitive pressures and stock volatility. The current valuation at 43.61 P/E requires robust growth reinstatement to justify upside.
Select Medical Holdings Corporation (SEM) trades at $16.51, unchanged on the day, with a mixed technical picture showing bullish oscillators but bearish moving averages. Recent earnings show volatility with Q3 2025 beating estimates but Q1 2026 missing, while valuation ratios like P/E of 15.43 and P/S of 0.36 suggest moderate pricing. The company announced a $0.06 dividend for H1 2026, but news highlights its acquisition completion by a consortium led by Robert A. Ortenzio in June 2026, with legal investigations into the fairness of the $16.50 per share deal.
The outlook is clouded by acquisition-related uncertainties and legal scrutiny, posing risks to shareholder value. Analyst consensus leans neutral with 57.15% hold ratings, reflecting cautious sentiment amid the takeover. Investors should weigh the stable fundamentals against potential dilution or litigation outcomes, with the stock's near-term direction tied to resolution of these corporate actions.
Trailing returns across standard periods
Latest headlines on both assets
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →Select Medical Holdings Corporation is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's services focus on treating patients with serious illnesses, injuries, and post-acute care needs. SEM provides specialized care across various settings, aiming to help patients recover and return home.
Read more on SEM →